Biotech RadarJobs updated

COMPANY

Tissue Regenix

HQ: Universal City, TX source · tissueregenix.com ↗

FDA-cleared device company

Keywords: regenerative medicine Knee Injuries Multiligament Knee Injuries Peripheral Arterial Vascular Occlusion OrthoPure XT dCELL® ACL Scaffold dCELL® Meniscus dCell Vascular Patch

Location: Universal City, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

4Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): OrthoPureXT Multiligament PMCF Study source ↗
  2. Trial start Not phased (device or behavioral study): Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate Ligament source ↗
  3. Trial start Not phased (device or behavioral study): Clinical Evaluation of dCELL® Meniscus for Partial Replacement of the Meniscus source ↗
  4. Trial start Not phased (device or behavioral study): dCell Vascular Patch in Peripheral Vascular Surgery Study for CE Mark Submission source ↗

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT05655156OrthoPureXT Multiligament PMCF StudyNot phased (device or behavioral study)Recruiting2025-042026-05 (estimated)
NCT02540811Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate LigamentNot phased (device or behavioral study)Completed2015-09Aug 11, 2021 (actual)
NCT02270905Clinical Evaluation of dCELL® Meniscus for Partial Replacement of the MeniscusNot phased (device or behavioral study)Suspended2014-102018-12 (estimated)
NCT00958230dCell Vascular Patch in Peripheral Vascular Surgery Study for CE Mark SubmissionNot phased (device or behavioral study)Completed2009-082010-04 (actual)
Feedback